Immediate Impact

4 by Nobel laureates 12 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Natural killer cell therapies
2024 StandoutNature
ImmunoPET: Concept, Design, and Applications
2020 Standout
3 intermediate papers

Works of Nancy Wedel being referenced

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia
2005
Phase I/II Study of Murine Monoclonal Antibody-Ricin A Chain (XOMAZYME-Mel) Immunoconjugate plus Cyclosporine A in Patients with Metastatic Melanoma
1993

Author Peers

Author Last Decade Papers Cites
Nancy Wedel 493 82 267 188 23 930
P. A. Gorer 487 133 259 95 20 1.0k
Akihiko Ohwada 186 49 426 221 34 1.0k
R H Lin 534 67 234 149 19 1.2k
A K Duwe 498 100 208 120 16 998
Kenneth J. Gorelick 310 63 130 81 33 769
Jose L. Lepe‐Zuniga 341 49 208 183 19 920
Hsiu-san Lin 291 50 160 192 29 820
Yuling Wu 296 24 377 126 31 823
Margot O’Toole 746 72 174 148 28 1.1k
Adrian M. Duijvestijn 541 98 202 88 26 1.1k

All Works

Loading papers...

Rankless by CCL
2026